| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 36,016 | 82,096 | 81,691 | 94,549 | | Cost of Revenue | 37,767 | 74,481 | 77,336 | 92,838 | | | Gross Profit | (1,751) | 7,615 | 4,355 | 1,711 | | | Operating Expenses | | Research Development | 267 | 1,032 | 1,168 | 1,175 | | Selling General and Administrative | 1,767 | 9,362 | 10,472 | 9,965 | | Non Recurring | 1,528 | 1,732 | 1,981 | 44,871 | | Others | 28 | 28 | 28 | 42 | | | | Total Operating Expenses | 3,590 | 12,154 | 13,649 | 56,053 | | | | Operating Income or Loss | (5,341) | (4,539) | (9,294) | (54,342) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 384 | (307) | (68,456) | | Earnings Before Interest And Taxes | (9,323) | (4,155) | (9,601) | (122,798) | | Interest Expense | (3,572) | 2,303 | 1,269 | 1,167 | | Income Before Tax | (5,751) | (6,458) | (10,870) | (123,965) | | Income Tax Expense | (3,804) | 320 | 475 | (1,715) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,947) | (6,778) | (11,345) | (122,250) | | | Non-recurring Events | | Discontinued Operations | 178 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,769) | (6,778) | (11,345) | (122,250) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,769) | ($6,778) | ($11,345) | ($122,250) |
|
0.51% Nasdaq 
0.01 (0.34%) 
Income Statement
